Log in
Enquire now
‌

US Patent 11918582 Pyrazole pyrimidine compounds and uses thereof

Patent 11918582 was granted and assigned to RAPT Therapeutics on March, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
RAPT Therapeutics
RAPT Therapeutics
0
Current Assignee
RAPT Therapeutics
RAPT Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
119185820
Patent Inventor Names
Mikhail Zibinsky0
Adrian Dukes0
Grant Shibuya0
Paul Leger0
Dennis Hu0
Jeffrey J. Jackson0
Omar Robles0
Parcharee Tivitmahaisoon0
...
Date of Patent
March 5, 2024
0
Patent Application Number
176946420
Date Filed
March 14, 2022
0
Patent Primary Examiner
‌
Kortney L. Klinkel
0
CPC Code
‌
A61P 35/00
0
‌
A61P 31/12
0
‌
A61P 31/04
0
‌
C07D 519/00
0
‌
A61K 45/06
0
‌
A61K 31/519
0
‌
A61P 31/00
0
‌
C07D 487/04
0
Patent abstract

Disclosed herein are pyrazole pyrimidine compounds that modulate and/or inhibit hematopoietic progenitor kinase 1, as well as methods of making such compounds and therapeutic methods of using same.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11918582 Pyrazole pyrimidine compounds and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.